The role of epigenetic modifications in drug resistance and treatment of breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of epigenetic modifications in drug resistance and treatment of breast cancer
Authors
Keywords
-
Journal
CELLULAR & MOLECULAR BIOLOGY LETTERS
Volume 27, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-28
DOI
10.1186/s11658-022-00344-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
- (2022) Parisa Maleki Dana et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Anti-cancer peptide-based therapeutic strategies in solid tumors
- (2022) Mohsen Karami Fath et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
- (2021) Masoumeh Moslemi et al. BMC CANCER
- Beyond K48 and K63: non-canonical protein ubiquitination
- (2021) Michal Tracz et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
- (2021) Aleksandra Majchrzak-Celińska et al. Genes
- Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival
- (2021) Shahad W. Kattan et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Epigenetic mechanisms in breast cancer therapy and resistance
- (2021) Liliana Garcia-Martinez et al. Nature Communications
- miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
- (2021) Maria Teresa Di Martino et al. Cancers
- MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer
- (2021) Sugang Ma et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
- (2020) Guotai Xu et al. NATURE GENETICS
- Pembrolizumab and atezolizumab in triple-negative breast cancer
- (2020) Dorota Kwapisz CANCER IMMUNOLOGY IMMUNOTHERAPY
- Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1
- (2020) Minhao Lv et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- EZH2 inhibitor GSK126 suppresses anti-tumor immunity by driving production of myeloid-derived suppressor cells
- (2019) Shuo Huang et al. CANCER RESEARCH
- Genomic characterization of metastatic breast cancers
- (2019) François Bertucci et al. NATURE
- Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
- (2019) Andrew T. Ludlow et al. Cancers
- Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
- (2019) Abel H. Y. Tan et al. Frontiers in Immunology
- Drug repurposing for breast cancer therapy: Old weapon for new battle
- (2019) Sadhna Aggarwal et al. SEMINARS IN CANCER BIOLOGY
- Targeting DNA methylation for treating triple-negative breast cancer
- (2019) Jia Yu et al. PHARMACOGENOMICS
- LSD1/KDM1A inhibitors in clinical trials: advances and prospects
- (2019) Yuan Fang et al. Journal of Hematology & Oncology
- Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
- (2018) Naveen K.R. Chalakur-Ramireddy et al. BIOSCIENCE REPORTS
- New emerging roles of microRNAs in breast cancer
- (2018) Edna Ayerim Mandujano-Tinoco et al. BREAST CANCER RESEARCH AND TREATMENT
- HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance
- (2018) Shou Liu et al. CANCER RESEARCH
- MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells
- (2018) Chengsen Chai et al. CARCINOGENESIS
- Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
- (2018) Qiang Wang et al. CELL RESEARCH
- Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
- (2018) Barbara Pasculli et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis
- (2018) Francesca Ricciardiello et al. Cell Death & Disease
- Nonredundant, Highly Connected MicroRNAs Control Functionality in Breast Cancer Networks
- (2018) Guillermo de Anda-Jáuregui et al. International Journal of Genomics
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
- (2018) Pedram Razavi et al. CANCER CELL
- Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer
- (2018) Ying Zhang et al. OncoTargets and Therapy
- Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
- (2018) Jonathan T. Lei et al. Cell Reports
- Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
- (2018) Zhiqiang Li et al. CANCER CELL
- Role of miRNAs in Immune Responses and Immunotherapy in Cancer
- (2018) Maria Angelica Cortez et al. GENES CHROMOSOMES & CANCER
- Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors
- (2018) Wanyu Sun et al. Genes
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling
- (2017) Chao Liu et al. ONCOLOGY REPORTS
- Epigenetics in cancer: Fundamentals and Beyond
- (2017) Subhankar Biswas et al. PHARMACOLOGY & THERAPEUTICS
- The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model
- (2017) L. Stankevicins et al. PLoS One
- P53-miR-191- SOX4 regulatory loop affects apoptosis in breast cancer
- (2017) Shivani Sharma et al. RNA
- The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
- (2017) Fernando Janczur Velloso et al. OncoTargets and Therapy
- MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells
- (2017) Christian Breunig et al. Cell Death & Disease
- DNA methylation and DNA methyltransferases
- (2017) John R. Edwards et al. Epigenetics & Chromatin
- MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
- (2017) Giuseppina Roscigno et al. Oncotarget
- HDAC inhibition potentiates immunotherapy in triple negative breast cancer
- (2017) Manuela Terranova-Barberio et al. Oncotarget
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
- (2017) Yuan Miao et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer
- (2016) Sho Shiino et al. Clinical Breast Cancer
- Bromodomain inhibitors and cancer therapy: From structures to applications
- (2016) Montserrat Pérez-Salvia et al. Epigenetics
- MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer
- (2016) HAITAO GUAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts
- (2015) Christian Jackisch et al. Breast Care
- Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
- (2015) Andrew McGuire et al. CANCER AND METASTASIS REVIEWS
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Targeting Of miR9/NOTCH1 Interaction Reduces Metastatic Behavior in Triple-negative Breast Cancer
- (2015) Samira Mohammadi-Yeganeh et al. Chemical Biology & Drug Design
- FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3
- (2015) Liqing Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies
- (2015) Ke Yang et al. LABORATORY INVESTIGATION
- miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α
- (2015) ZHIHAO WU et al. ONCOLOGY REPORTS
- Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- (2015) Van T. M. Nguyen et al. Nature Communications
- miR-200c inhibits breast cancer proliferation by targeting KRAS
- (2015) Cailu Song et al. Oncotarget
- HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
- (2015) Neha Nagpal et al. Scientific Reports
- Signal Transduction in Cancer
- (2015) R. Sever et al. Cold Spring Harbor Perspectives in Medicine
- MicroRNA Regulation of Human Breast Cancer Stem Cells
- (2015) Yohei Shimono et al. Journal of Clinical Medicine
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- miR-155 Drives Telomere Fragility in Human Breast Cancer by Targeting TRF1
- (2014) R. Dinami et al. CANCER RESEARCH
- Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
- (2014) Hanna K. Sanoff et al. JNCI-Journal of the National Cancer Institute
- Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia
- (2014) Carme Camps et al. Molecular Cancer
- CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2
- (2014) Nicole Boucheron et al. NATURE IMMUNOLOGY
- Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
- (2014) Bo Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two Decades
- (2012) R. Haque et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells
- (2012) P. Qian et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/β-catenin signaling
- (2010) Xiao-lei Zhou et al. ACTA PHARMACOLOGICA SINICA
- Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation
- (2009) Sebastian Schmeier et al. BMC GENOMICS
- Histone Deacetylase 7 and FoxA1 in Estrogen-Mediated Repression of RPRM
- (2009) S. Malik et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetics of endometriosis
- (2009) S.-W. Guo MOLECULAR HUMAN REPRODUCTION
- The epidermal growth factor receptor family: Biology driving targeted therapeutics
- (2008) M. J. Wieduwilt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started